HEALTHCARE4/13/2026 • LIVE

TEBio-Techne Corporation (TECH)

Bio-Techne Corporation (TECH) is a healthcare company operating in biotechnology. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

PRICE
$55.54
-0.05% today
RISK
MEDIUM
Share this asset

Key Metrics

MARKET CAP
$8.69B
P/E RATIO
104.8
BETA
1.49
More volatile
DIV YIELD
0.58%
52W HIGH
$72.16
52W LOW
$46.01
VOLATILITY
30.0%
30d annualized

Price Performance

30-DAY PRICE CHART

$50.85 → $55.54+9.22%
30 days agoToday

1-YEAR PERFORMANCE

$48.10 → $55.54+15.5%
$51$58$65AprMayJunJulAugSepOctNovDecJanFebMar
TECH | 52-week chartLast updated: 4/13/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRICTECHSECTOR AVGVS SECTOR
P/E Ratio104.8x22.0x 376%
Beta1.490.85More volatile
Div Yield0.58%1.50%Below avg
30d Volatility30.0%22%Higher risk

TOP HEALTHCARE PEERS

Competitors Analysis

Compare TECH's key metrics against its main healthcare sector competitors.

COMPANYPRICEMARKET CAPSECTOR
TETECH(You are here)
$55.54$8.69BHealthcare
$304.33$276.23BHealthcareVIEW →
$238.46$574.66BHealthcareVIEW →
PFPFE
$26.92$153.13BHealthcareVIEW →
Click on a competitor to view their full analysis

Technical Analysis

Bio-Techne Corporation is currently trading at $55.54, which is 23.0% below its 52-week high. With a beta of 1.49, the stock shows higher sensitivity to market movements.

RSI (14)OVERBOUGHT
30-DAY TRENDBULLISH
VOLUME1.2M(Below avg)

Frequently Asked Questions

Is TECH a good buy right now?

Bio-Techne Corporation trades at 104.8x earnings. This is above market average, reflecting growth expectations. Current risk level is Medium based on 30.0% volatility.

Does TECH pay dividends?

Yes, Bio-Techne Corporation offers a dividend yield of 0.58%. This translates to approximately $0.32 per share annually.

How volatile is TECH?

With 30-day annualized volatility of 30.0% and beta of 1.49,TECH is classified as Medium risk. Expect larger swings than the broader market during volatile periods.

Related Assets

Track TECH Live

Add Bio-Techne Corporation to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINALIMPORT BROKER FILE
Last updated: 4/13/2026, 8:52:06 AM